{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:05Z","timestamp":1790685845141,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jid.2019.09.009","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T18:03:59Z","timestamp":1576865039000},"page":"531-536.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8132-1997","authenticated-orcid":false,"given":"Mondana H.","family":"Ghias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-9841","authenticated-orcid":false,"given":"Michael J.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4545-7138","authenticated-orcid":false,"given":"Lewis E.","family":"Tomalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-7676","authenticated-orcid":false,"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-4917","authenticated-orcid":false,"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-478X","authenticated-orcid":false,"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-4517","authenticated-orcid":false,"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2019.09.009_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian hidradenitis suppurativa foundations. part I: Diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J\u00a0Am Academy Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American Clinical Management Guidelines for Hidradenitis suppurativa: a Publication from the United States and Canadian Hidradenitis\u00a0suppurativa Foundations. part II: Topical, intralesional, and Systemic medical Management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J\u00a0Am Academy Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/eji.201546131","article-title":"A\u00a0novel \"complement-metabolism-inflammasome axis\" as a key regulator of immune cell effector function","volume":"46","author":"Arbore","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2017.03.009","article-title":"Therapeutic inhibition of complement: well worth the risk","volume":"38","author":"Barnum","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jid.2019.09.009_bib5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.1260144","article-title":"Dialogue between skin microbiota and immunity","volume":"346","author":"Belkaid","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jid.2019.09.009_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00431-014-2476-2","article-title":"The intestinal microbiota: its role in health and disease","volume":"174","author":"Biedermann","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jid.2019.09.009_bib7","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1073\/pnas.1307855110","article-title":"Complement modulates the cutaneous microbiome and inflammatory milieu","volume":"110","author":"Chehoud","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2019.09.009_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature25177","article-title":"Skin microbiota-host interactions","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jid.2019.09.009_bib9","first-page":"23","article-title":"Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment","volume":"30","author":"Chimenti","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2019.09.009_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1189\/jlb.3MR0214-109R","article-title":"Complement modulation of T cell immune responses during homeostasis and disease","volume":"96","author":"Clarke","year":"2014","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2019.09.009_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007353","article-title":"Innate antimicrobial immunity in the skin: A protective barrier against bacteria, viruses, and fungi","volume":"14","author":"Coates","year":"2018","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.jid.2019.09.009_bib84","doi-asserted-by":"crossref","first-page":"e0216249","DOI":"10.1371\/journal.pone.0216249","article-title":"The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin","volume":"14","author":"Coates","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2019.09.009_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2018-12-891499","article-title":"Ravulizumab: a complementary option for PNH","volume":"133","author":"Connell","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.09.009_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/039463201102400209","article-title":"Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment","volume":"24","author":"Di Muzio","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jid.2019.09.009_bib14","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12688\/f1000research.17267.1","article-title":"A\u00a0systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa","volume":"7","author":"Frew","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jid.2019.09.009_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/exd.13978","article-title":"Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa\/ acne inversa","volume":"28","author":"Frew","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.15441","article-title":"A\u00a0systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa","volume":"177","author":"Frew","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jid.2016.11.011","article-title":"Complement C3 exacerbates imiquimod-induced skin inflammation and psoriasiform dermatitis","volume":"137","author":"Giacomassi","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib20","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3201\/eid2012.140064","article-title":"Bacterial pathogens associated with hidradenitis suppurativa, France","volume":"20","author":"Guet-Revillet","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jid.2019.09.009_bib86","unstructured":"Guo R, Habel M, Zenker O, Giamarellos-Bourboulis EJ, Riedemann NC. IFX-1 blocking the anaphylatoxin C5a \u2013 an anti-inflammatory effect in patients with hidradenitis suppurativa. Poster presented at: 16th European Meeting on Complement in Human Disease (EMCHD2017), Copenhagen, 2017. https:\/\/www.inflarx.de\/Home\/Investors\/Publications---Posters.html (accessed 8 November 2019)."},{"key":"10.1016\/j.jid.2019.09.009_bib21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2016.08.003","article-title":"Complement-mediated regulation of metabolism and basic cellular processes","volume":"45","author":"Hess","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2019.09.009_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jid.2019.09.009_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"Hoffman","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jid.2019.09.009_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fimmu.2018.01057","article-title":"Complement in the initiation and evolution of rheumatoid arthritis","volume":"9","author":"Holers","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in Hidradenitis suppurativa","volume":"136","author":"Hotz","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib29","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor Avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jid.2019.09.009_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130522","article-title":"Compartmentalized cytokine responses in hidradenitis suppurativa","volume":"10","author":"Kanni","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jid.2019.09.009_bib31","first-page":"413","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","volume":"179","author":"Kanni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib32","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.1500516","article-title":"CD46 activation regulates miR-150-Mediated control of GLUT1 expression and cytokine secretion in human CD4+ T cells","volume":"196","author":"King","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.immuni.2015.03.014","article-title":"Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis","volume":"42","author":"Kobayashi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2019.09.009_bib34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood-2018-09-876805","article-title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study","volume":"133","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.09.009_bib35","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1038\/s41598-018-26387-4","article-title":"Development and validation of a LC-MS\/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice","volume":"8","author":"Kumar","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2019.09.009_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jid.2017.09.026","article-title":"Increasing the complement of therapeutic options in bullous pemphigoid","volume":"138","author":"Kushner","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.09.009_bib38","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2019.09.009_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","article-title":"Meningococcal disease and the complement system","volume":"5","author":"Lewis","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.jid.2019.09.009_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski","year":"2015","journal-title":"Hum Genomics"},{"key":"10.1016\/j.jid.2019.09.009_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhep.2014.08.050","article-title":"C5aR, TNF-alpha, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis","volume":"62","author":"Liu","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2019.09.009_bib42","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1128\/JVI.76.18.9232-9241.2002","article-title":"Herpes simplex virus type 1 evades the effects of antibody and complement in\u00a0vivo","volume":"76","author":"Lubinski","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2019.09.009_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09546634.2017.1395806","article-title":"Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials","volume":"29","author":"Maarouf","year":"2018","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jid.2019.09.009_bib44","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.4049\/jimmunol.1400569","article-title":"Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis","volume":"192","author":"Maekawa","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1399-302X.2009.00532.x","article-title":"Porphyromonas gingivalis mediates the shedding and proteolysis of complement regulatory protein CD46\u00a0expressed by oral epithelial cells","volume":"24","author":"Mahtout","year":"2009","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.seminhematol.2018.02.002","article-title":"Expanding Complement Therapeutics for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"55","author":"Mastellos","year":"2018","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jid.2019.09.009_bib47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-019-01068-2","article-title":"Ravulizumab: first global approval","volume":"79","author":"McKeage","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jid.2019.09.009_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2019.09.009_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jid.2018.09.036","article-title":"Are bacteria infectious pathogens in hidradenitis suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017","volume":"139","author":"Naik","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib51","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.09.009_bib52","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41598-018-20220-8","article-title":"The inflammatory effects of TNF-alpha and complement component 3 on coagulation","volume":"8","author":"Page","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2019.09.009_bib53","first-page":"3","article-title":"Complement system in dermatological diseases - fire under the skin","volume":"2","author":"Panelius","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2019.09.009_bib54","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3389\/fimmu.2017.01955","article-title":"The role of skin and orogenital microbiota in protective immunity and chronic immune-mediated inflammatory disease","volume":"8","author":"Park","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1515\/hsz-2012-0174","article-title":"Protease-dependent mechanisms of complement evasion by bacterial pathogens","volume":"393","author":"Potempa","year":"2012","journal-title":"Biol Chem"},{"key":"10.1016\/j.jid.2019.09.009_bib56","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4049\/jimmunol.1402354","article-title":"Complement deficiency promotes cutaneous wound healing in mice","volume":"194","author":"Rafail","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2017.03.012","article-title":"Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition","volume":"180","author":"Riedemann","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib58","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"33","author":"Ring","year":"2019","journal-title":"J\u00a0Eur Academy Dermatol Venereol"},{"key":"10.1016\/j.jid.2019.09.009_bib59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib60","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4049\/jimmunol.1500960","article-title":"TNF regulates essential alternative complement pathway components and impairs activation of protein C in human glomerular endothelial cells","volume":"196","author":"Sartain","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib62","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cmi.2016.04.018","article-title":"Koch's postulates, microbial dysbiosis and inflammatory bowel disease","volume":"22","author":"Singh","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 4","key":"10.1016\/j.jid.2019.09.009_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nep.13461","article-title":"Complement in glomerular diseases","volume":"23","author":"Tan","year":"2018","journal-title":"Nephrol (Carlton)"},{"key":"10.1016\/j.jid.2019.09.009_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13543784.2018.1412430","article-title":"Investigational drugs in clinical trials for Hidradenitis suppurativa","volume":"27","author":"Theut Riis","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jid.2019.09.009_bib65","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: A systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib66","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/bjd.12234","article-title":"Myeloid marker S100A8\/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?","volume":"168","author":"Wieland","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/imt-2018-0090","article-title":"Biologics for hidradenitis suppurativa: an update","volume":"11","author":"W\u0142odarek","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jid.2019.09.009_bib68","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/bjd.15424","article-title":"Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa \/ hidradenitis suppurativa","volume":"177","author":"Wolk","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib69","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.biocel.2013.09.016","article-title":"CD46: the 'multitasker' of complement proteins","volume":"45","author":"Yamamoto","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jid.2019.09.009_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2018.09.011","article-title":"Accelerated aging and clearance of host anti-inflammatory enzymes by discrete pathogens fuels sepsis","volume":"24","author":"Yang","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jid.2019.09.009_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1871528113666140522112003","article-title":"Inflammaging in skin and other tissues - the roles of complement system and macrophage","volume":"13","author":"Zhuang","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.jid.2019.09.009_bib72","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molimm.2005.02.017","article-title":"Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis","volume":"43","author":"Bathum","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jid.2019.09.009_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molimm.2017.05.020","article-title":"The role of the complement system in hereditary angioedema","volume":"89","author":"Csuka","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jid.2019.09.009_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"Hoffman","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jid.2019.09.009_bib77","first-page":"413","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","volume":"179","author":"Kanni","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.09.009_bib78","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2019.09.009_bib79","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2019.09.009_bib80","first-page":"3","article-title":"Complement system in dermatological diseases - fire under the skin","volume":"2","author":"Panelius","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2019.09.009_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jid.2019.09.009_bib82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/07853890.2016.1162909","article-title":"Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment","volume":"48","author":"Zeerleder","year":"2016","journal-title":"Ann Med"},{"key":"10.1016\/j.jid.2019.09.009_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: systemic\u00a0lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatol (Oxf)"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19333019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19333019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:17:21Z","timestamp":1758302241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X19333019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0022202X19333019"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2019.09.009","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2019.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}